Emergent BioSolutions Inc.

EBS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$6.43-5.58%

2026-11-02

Financials

Valuation Metrics

Emergent BioSolutions Inc.'s Market Cap is $332M. At end of 2025 it was $661M. Ranked #2861 of 3,118 in US market (top 92%), #1582 of 1,644 on NYSE (top 96%), #227 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 86%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$332M	US#2,861/3,118 Sec#227/265
Revenue	$770M	US#2,021/3,118 Sec#64/265
Net Income	$-177M	US—/3,118 Sec—/265
Total Assets	$1.12B	US#2,415/3,118 Sec#93/265
Net Assets	$341M	US#2,454/3,118 Sec#150/265
Value
P/B	0.97x	US#426/3,118 Sec#24/265
P/S	0.43x	US#295/3,118 Sec#4/265
FCF Yield	25.89%	US#132/3,118 Sec#5/265
Profitability
ROE	-51.79%	US#2,679/3,118 Sec#159/265
ROA	-15.83%	US#2,745/3,118 Sec#123/265
Op. Margin	-7.06%	US#2,482/3,118 Sec#88/265
Revenue Growth	-9.56%	US#2,546/3,118 Sec#143/265
Earnings Growth	-226.74%	US#1,936/3,118 Sec#62/265
Financial Health
Debt Ratio	227.12%	US#1,890/3,118 Sec#203/265
Total Debt	$582M	US#1,789/3,118 Sec#61/265
FCF	$86M	US#1,789/3,118 Sec#64/265
Cash	$140M	US#1,990/3,118 Sec#138/265
Current Ratio	5.42x	US#432/3,118 Sec#132/265
Performance
1Y Return	-48.48%	US#2,830/3,118 Sec#230/265
1M Return	1.58%	US#1,483/3,118 Sec#88/265
From 52W High	-54.27%	US#2,668/3,118 Sec#203/265
1Y MDD	-67.99%	US#2,898/3,118 Sec#232/265
Trading
Volume	685,402 shares	US#1,910/3,118 Sec#187/265
Trading Value	$4M	US#2,680/3,118 Sec#217/265
Per Share
EPS	$-3.43	US—/3,118 Sec—/265
BPS	$6.62	US#2,127/3,118 Sec#106/265